Evaluation of Anti-Mullerian Hormone in Predicting In Vitro Fertilization Cycle Outcomes

Basit Öğe Kaydı
dc.contributor.authorŞanlıer, Nazlı
dc.contributor.authorGüvey, Huri
dc.contributor.authorKahyaoğlu, İnci
dc.contributor.authorÜstün, Yaprak Engin
dc.contributor.authorDilbaz, Serdar
dc.contributor.authorErdoğan, Kadriye
dc.date.accessioned2023-04-10T20:21:03Z
dc.date.available2023-04-10T20:21:03Z
dc.date.issued2022
dc.departmentRektörlük, Rektörlüğe Bağlı Birimler, Düzce Üniversitesi Dergilerien_US
dc.description.abstractAim: This study was conducted to explore the effect of serum anti-Mullerian hormone (AMH) level on in vitro fertilization (IVF) cycle outcomes. Material and Methods: A total of 142 patients included in this study, were divided into three groups according to their serum AMH levels as Group 1: AMH level 5-10 ng/ml (n=108), Group 2: AMH level 10-15 ng/ml (n=20), and Group 3: AMH level >15 ng/ml (n=14). Demographic characteristics were recorded. The duration of infertility and stimulation, the number of cycles, initial, final, and total doses of gonadotropins, and estradiol (E2) and progesterone levels on the day of trigger, oocyte pick up (OPU) and embryo transfer (ET), the total number of oocytes retrieved, the number of mature oocytes, the number and quality of the embryo, and also endometrial thickness on the day of trigger, OPU and ET, the distance of embryo-fundus, the day of ET, and pregnancy outcomes were all recorded. Results: While the IVF treatment indications and pregnancy outcomes were similar between the groups, body mass index (BMI) was significantly higher in Group 2 and Group 3 than in Group 1 (p<0.001). The total doses of gonadotropin were significantly higher in Group 2 than in Group 1 and Group 3, and the total oocyte count was also significantly higher in Group 3 than in Group 1 (p=0.006, and p=0.015, respectively) Conclusion: AMH levels were associated with BMI and total oocyte count, but not with mature oocyte count, oocyte quality, and pregnancy outcomes.en_US
dc.identifier.doi10.18678/dtfd.1198037
dc.identifier.endpage332en_US
dc.identifier.issn1307-671X
dc.identifier.issue3en_US
dc.identifier.startpage328en_US
dc.identifier.trdizinid1146385en_US
dc.identifier.urihttp://doi.org/10.18678/dtfd.1198037
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1146385
dc.identifier.urihttps://hdl.handle.net/20.500.12684/11537
dc.identifier.volume24en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofDüzce Tıp Fakültesi Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAMH levelsen_US
dc.subjectIVF cycle outcomesen_US
dc.subjectBMIen_US
dc.subjectoocyte count and qualityen_US
dc.subjectpregnancy outcomes AMH seviyelerien_US
dc.subjectIVF siklus sonuçlarıen_US
dc.subjectVKİen_US
dc.subjectoosit sayısı ve kalitesien_US
dc.subjectgebelik sonuçlarıen_US
dc.titleEvaluation of Anti-Mullerian Hormone in Predicting In Vitro Fertilization Cycle Outcomesen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
11537.pdf
Boyut:
392.96 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu
Düzce Tıp Fakültesi Dergisi Koleskiyonu